By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Gendux AB 

Högbergsgatan 32

Stockholm    SE-116 20  Sweden
Phone: 46-8-556-091-89 Fax: 46-8-442-72-39


SEARCH JOBS
AUSTIN, Texas and LONDON, Sept. 17 /PRNewswire/ -- Introgen Therapeutics,
a world leader in the development of gene-based therapeutics to treat cancer,
today announced the formation of Gendux Inc., a wholly owned subsidiary.
Gendux will utilize the product development and manufacturing processes,
research and development infrastructure, clinical and regulatory expertise,
business development and licensing experience and proven gene delivery
technologies of Introgen Therapeutics, to move its therapeutic candidates to
product commercialization in a rapid timeframe.


Key Statistics


Email: info@gendux.com
Ownership: Private

Web Site: Gendux
Employees:
Symbol: 
 



Industry
Biotechnology

Segment
Gene Therapy





Company News
//-->